Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 103-111

  George, M Patricia ^a   Brower, Alexandra ^b   Kling, Heather ^a   Shipley, Tim ^a   Kristoff, Jan ^a   Reinhart, Todd A ^c   Murphey Corb, Michael ^a   Gladwin, Mark T ^a   Champion, Hunter C ^a   Morris, Alison ^a   Norris, Karen A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ANIMAL TISSUE; ARTERY MEDIA; ARTICLE; AUTOPSY; CELL HYPERPLASIA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPLASIA; INTIMA; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MACACA; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VASCULAR DISEASE; SIMIAN IMMUNODEFICIENCY VIRUS; SMOOTH MUSCLE FIBER; VASCULAR LESION;

ANIMALS; BLOOD VESSELS; BRONCHOALVEOLAR LAVAGE FLUID; HIV; IMMUNOHISTOCHEMISTRY; LUNG; MACACA FASCICULARIS; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79951707100     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0297     Document Type: Article

References (38)

1. Crum NF, Riffenburgh RH, Wegner S, et al.: Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41(2):194-200.
2. Speich R, Jenni R, Opravil M, Pfab M, and Russi EW: Primary pulmonary hypertension in HIV infection. Chest 1991;100(5):1268-1271.
3. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al.: Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008;177(1):108-113.
4. Hsue PY, Deeks SG, Farah HH, et al.: Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 2008;22(7):825-833. (Pubitemid 351563831)
5. Nunes H, Humbert M, Sitbon O, et al.: Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003;167(10):1433-1439. (Pubitemid 36609730)
6. Recusani F, Di Matteo A, Gambarin F, D'Armini A, Klersy C, and Campana C: Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: Prospective study of 10 patients. AIDS 2003;17(Suppl 1):S88-95. (Pubitemid 36667786)
7. Ghofrani HA, Friese G, Discher T, et al.: Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension. Eur Respir J 2004;23(2):321-326. (Pubitemid 38202132)
8. Sitbon O, Gressin V, Speich R, et al.: Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;170(11):1212-1217. (Pubitemid 39577380)
9. Barbaro G, Lucchini A, Pellicelli AM, Grisorio B, Giancaspro G, and Barbarini G: Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension. Heart 2006;92(8):1164-1166. (Pubitemid 44125252)
10. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, and Reid L: Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features. Am J Physiol 1979; 236(6):H818-827.
11. Okada K, Tanaka Y, Bernstein M, Zhang W, Patterson GA, and Botney MD: Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 1997;151(4):1019-1025. (Pubitemid 27424311)
12. Shacklett BL: Can the new humanized mouse model give HIV research a boost. PLoS Med 2008;5(1):e13.
13. Rahim MM, Chrobak P, Hu C, Hanna Z, and Jolicoeur P: Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia. J Virol 2009;83(22):11830-11846.
14. Van Duyne R, Pedati C, Guendel I, et al.: The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology 2009;6:76.
15. Hu SL: Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 2005;5(2):193-201.
16. Chalifoux LV, SimonMA, Pauley DR,MacKey JJ, WyandMS, and Ringler DJ:Arteriopathy inmacaques infectedwith simian immunodeficiency virus. Lab Invest 1992;67(3):338-349.
17. Marecki JC, Cool CD, Parr JE, et al.: HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nefinfected macaques. Am J Respir Crit Care Med 2006;174(4): 437-445. (Pubitemid 44223125)
18. Mette SA, Palevsky HI, Pietra GG, et al.: Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992;145(5):1196-1200.
19. Caldwell RL, Gadipatti R, Lane KB, and Shepherd VL: HIV- 1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. J Leukoc Biol 2006;79(1):192-201. (Pubitemid 43054265)
20. Sehgal PB, Mukhopadhyay S, Patel K, et al.: Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol 2009; 297(4):L729-737.
21. Swain SD, Han S, Harmsen A, Shampeny K, and Harmsen AG: Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia. Am J Pathol 2007;171: 790-799. (Pubitemid 47440978)
22. Mehta NJ, Khan IA, Mehta RN, and Sepkowitz DA: HIVRelated pulmonary hypertension: Analytic review of 131 cases. Chest 2000;118(4):1133-1141.
23. Pellicelli AM, Barbaro G, Palmieri F, et al.: Primary pulmonary hypertension in HIV patients: A systematic review. Angiology 2001;52(1):31-41. (Pubitemid 32113205)
24. Barouch DH, Fu TM, Montefiori DC, Lewis MG, Shiver JW, and Letvin NL: Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. Immunol Lett 2001;79(1-2):57-61. (Pubitemid 32938208)
25. Reimann KA, Li JT, Voss G, et al.: An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/ human immunodeficiency virus in rhesus monkeys. J Virol 1996;70(5):3198-3206. (Pubitemid 26121938)
26. Reimann KA, Li JT, Veazey R, et al.: A chimeric simian/ human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 1996;70(10):6922-6928. (Pubitemid 26307405)
27. Pietra GG, Capron F, Stewart S, et al.: Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:25-32.
28. Board KF, Patil S, Lebedeva I, et al.: Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virusinfected rhesus macaques. J Infect Dis 2003;187(4):576-588. (Pubitemid 36250021)
29. Kling HM, Shipley TW, Patil S, Morris A, and Norris KA: Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques. J Infect Dis 2009;199(1):89-96.
30. Wakefield AE, Pixley FJ, Banerji S, et al.: Detection of Pneumocystis carinii with DNA amplification. Lancet 1990; 336(8713):451-452.
31. Joag SV: Primate models of AIDS. Microbes Infect 2000;2(2): 223-229. (Pubitemid 30154711)
32. Rusnati M and Presta M: HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies. Angiogenesis 2002;5(3):141-151. (Pubitemid 36687517)
33. Ehrenreich H, Rieckmann P, Sinowatz F, et al.: Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 1993;150(10):4601-4609. (Pubitemid 23133737)
34. Kanmogne GD, Primeaux C, and Grammas P: Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 2005;333(4):1107-1115. (Pubitemid 40910118)
35. Sinclair E, Barbosa P, and Feinberg MB: The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable. J Virol 1997;71(5):3641-3651. (Pubitemid 27172376)
36. Alexander L, Du Z, Howe AY, Czajak S, and Desrosiers RC: Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. J Virol 1999;73(7): 5814-5825. (Pubitemid 29274868)
37. Jacobs A, Preston IR, and Gomberg-Maitland M: Endothelin receptor antagonism in pulmonary arterial hypertension-a role for selective ET(A) inhibition. Curr Med Res Opinions 2006;22(12):2567-2574. (Pubitemid 46048372)
38. Giaid A, Yanagisawa M, Langleben D, et al.: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328(24):1732-1739. (Pubitemid 23170122)